Search by Drug Name or NDC

    NDC 70436-0206-80 sodium nitroprusside in 0.9% sodium chloride 0.2 mg/mL Details

    sodium nitroprusside in 0.9% sodium chloride 0.2 mg/mL

    sodium nitroprusside in 0.9% sodium chloride is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Slate Run Pharmaceuticals, LLC. The primary component is SODIUM NITROPRUSSIDE.

    Product Information

    NDC 70436-0206
    Product ID 70436-206_09c94d69-7bea-2491-e063-6394a90a6438
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name sodium nitroprusside in 0.9% sodium chloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name sodium nitroprusside in 0.9% sodium chloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 0.2
    Active Ingredient Units mg/mL
    Substance Name SODIUM NITROPRUSSIDE
    Labeler Name Slate Run Pharmaceuticals, LLC
    Pharmaceutical Class Vasodilation [PE], Vasodilator [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215846
    Listing Certified Through 2024-12-31

    Package

    NDC 70436-0206-80 (70436020680)

    NDC Package Code 70436-206-80
    Billing NDC 70436020680
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (70436-206-80) / 100 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2022-12-31
    NDC Exclude Flag N
    Pricing Information N/A
    << 70436-0205-80 70436-0207-80 >>

    Contents